Accuray | ARAY - Sales Revenues

Stock Price
0.47
Daily Change
0.01 2.65%
Monthly
20.03%
Yearly
-70.57%
Q2 Forecast
0.43

Accuray reported $116.17M in Sales Revenues for its fiscal quarter ending in December of 2024.





Sales Change Date
Abbott USD 11.16B 300M Mar/2026
Accuray USD 116.17M 14.63M Dec/2024
AngioDynamics USD 79.43M 3.72M Sep/2025
Artivion USD 115.99M 2.6M Dec/2025
AtriCure USD 140.5M 6.2M Dec/2025
Boston Scientific USD 5.2B 90M Mar/2026
Edwards Lifesciences USD 1.65B 80M Mar/2026
Inogen USD 74.93M 504K Sep/2024
Mesa Laboratories USD 62.84M 5.01M Dec/2024
Orthofix International USD 219.91M 14.28M Dec/2025
Surmodics USD 29.57M 355K Jun/2025
Tandem Diabetes Care USD 290.4M 41.15M Dec/2025
Trinity Biotech USD 14.31M 1.55M Sep/2025